A nano-engager for iNKT cells in cancer
Crossref DOI link: https://doi.org/10.1038/s43018-020-00138-9
Published Online: 2020-11-17
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Exley, Mark A.
Gensollen, Thomas
Blumberg, Richard S. http://orcid.org/0000-0002-9704-248X
Text and Data Mining valid from 2020-11-17
Version of Record valid from 2020-11-17
Article History
First Online: 17 November 2020
Competing interests
: M.A.E. is employed by Imvax, a cancer vaccine–based company, and acts as consultant for Agentus, a company developing iNKT cell–based therapies.